BTS Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,906
Closed -$348K 40
2025
Q2
$348K Buy
+30,906
New +$335K 0.42% 21
2025
Q1
Sell
-38,712
Closed -$458K 47
2024
Q4
$458K Sell
38,712
-268
-0.7% -$3.17K 0.46% 18
2024
Q3
$450K Buy
+38,980
New +$444K 0.43% 16

Other funds holding ROIV

BTS Asset Management's ROIV Position: Q3 2025 in Review

BTS Asset Management sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 30,906 shares — an estimated $348K sold.

BTS Asset Management first reported a position in ROIV in Q3 2024 and held it in 3 quarters. The position peaked at $458K in Q4 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • BTS Asset Management reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • BTS Asset Management sold 30,906 Roivant Sciences shares in Q3 2025, an estimated $348K.
  • BTS Asset Management first reported a position in Roivant Sciences in Q3 2024 and held it in 3 quarters.
  • BTS Asset Management's Roivant Sciences position peaked at $458K in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on BTS Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.